GTG Settles Patent Infringement Litigation with RGI | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic Technologies said late last week that it has settled with Reproductive Genetics Institute over allegations that RGI infringed GTG's patent covering its non-coding DNA technology.

Terms of the settlement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.